Akeso

Akeso
Favicon Fierce Pharma

Akeso CEO touts biliary tract win, counters ivonescimab debate

The Akeso CEO also pushed back against new debates around dataset fluctuations in NSCLC.
Angus Liu Aug 26, 2026 11:11am
ASCO
Favicon Fierce Pharma

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am
ASCO
Favicon Fierce Pharma

Akeso's 34% overall survival win comes with caveats

May 31, 2026 8:00am
Graphic of a fork in the road with arrows pointing in either direction

ASCO: BioNTech/BMS, Pfizer split on bispecific approach in NSCLC

May 30, 2026 3:30pm
lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm
Stock market drop
Favicon Fierce Pharma

Summit shares tumble on interim PD-1/VEGF trial miss

May 1, 2026 10:56am